Skip to content

The effect of Dydrogesterone and Cyclogest on threatend abortion

The comparison between the effect of Dydrogesterone and Cyclogest intake on consequences of pregnancy in threatend abortion.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120104008611N8
Enrollment
160
Registered
2018-09-22
Start date
2017-05-22
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Threatened abortion. Threatened abortion

Interventions

Intervention 1: Intervention group1: Progesterone vaginal suppository made by Abourihan Company, 400 milligrams only once per day since the initial of the study up to 16 weeks of pregnancy. Interventi

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Gestational age 6 to 13 weeks Observation of fetal heart rate Vaginal bleeding Uterine anomalies Fetal anomalies

Exclusion criteria

Exclusion criteria: Patient unwillingness Breast carcinoma Lack of fetal heart rate Severe liver problems Genital carcinoma Thromboembolic disorders Epilepsy Diabetes Hypertension

Design outcomes

Secondary

MeasureTime frame
Preeclampsia. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and thereafter weekly until delivery. Method of measurement: Mercury Barometer.;Gestational Diabetes. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and then weekly until delivery. Method of measurement: Glucose tolerance test.;Preterm labor. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and then weekly until delivery. Method of measurement: Tocometry of uterus and delivery before 37 weeks of pregnancy.;Low birth weight. Timepoint: Weight immediately after birth. Method of measurement: Pediatric scales.;Abortion under 20 weeks of pregnancy. Timepoint: Every week from the start of the intervention up to 20 weeks of pregnancy. Method of measurement: Questionnaire.

Primary

MeasureTime frame
Threatened abortion. Timepoint: Before intervention and 2 weeks after the completion of the intervention. Method of measurement: Weekly visit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr nushin kashanipoor

Qazvin University of Medical Sciences

Sayekam@yahoo.com+98 28 3333 3006

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026